A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/675 (2006.01) A61K 31/00 (2006.01) A61K 31/395 (2006.01) A61K 31/435 (2006.01) A61K 31/438 (2006.01) A61K 31/445 (2006.01) A61K 31/451 (2006.01) A61K 31/535 (2006.01) A61K 31/5375 (2006.01) A61K 31/5377 (2006.01) C07D 211/56 (2006.01) C07D 491/10 (2006.01)
Patent
CA 2273806
The present invention provides the use of an orally active, long acting, CNS- penetrant NK-1 receptor antagonist for the manufacture of a medicament adapted for oral administration for the treatment or prevention of substance use disorders, methods of treatment using such a NK-1 receptor antagonist and pharmaceutical compositions comprising the same.
La présente invention a pour objet l'utilisation d'un antagoniste du récepteur NK-1, à action prolongée, agissant sur le système nerveux central; et à administration par voie orale, dans la fabrication d'un médicament prévu pour être administré par voie orale permettant de traiter ou de prévenir les troubles du sevrage. L'invention traite également de procédés de traitement à l'aide d'un antagoniste du récepteur NK-1 et de compositions pharmaceutiques comprenant cet antagoniste.
Baker Raymond
Curtis Neil Roy
Elliott Jason Matthew
Harrison Timothy
Hollingworth Gregory John
Merck Sharp & Dohme Limited
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Use of nk-1 receptor antagonists for treating substance use... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of nk-1 receptor antagonists for treating substance use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of nk-1 receptor antagonists for treating substance use... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2045141